Works matching IS 09395555 AND DT 2021 AND VI 100 AND IP 8
Results: 32
Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1947, doi. 10.1007/s00277-021-04577-x
- By:
- Publication type:
- Article
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2031, doi. 10.1007/s00277-021-04574-0
- By:
- Publication type:
- Article
Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2071, doi. 10.1007/s00277-021-04571-3
- By:
- Publication type:
- Article
Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2079, doi. 10.1007/s00277-021-04568-y
- By:
- Publication type:
- Article
Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1929, doi. 10.1007/s00277-021-04567-z
- By:
- Publication type:
- Article
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Eculizumab, a real-life successful treatment for refractory cold agglutinin–mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients—a single-center retrospective study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2061, doi. 10.1007/s00277-021-04555-3
- By:
- Publication type:
- Article
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2043, doi. 10.1007/s00277-021-04548-2
- By:
- Publication type:
- Article
Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1965, doi. 10.1007/s00277-021-04546-4
- By:
- Publication type:
- Article
Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1921, doi. 10.1007/s00277-021-04532-w
- By:
- Publication type:
- Article
Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1983, doi. 10.1007/s00277-021-04513-z
- By:
- Publication type:
- Article
δ-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1953, doi. 10.1007/s00277-021-04510-2
- By:
- Publication type:
- Article
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2095, doi. 10.1007/s00277-021-04487-y
- By:
- Publication type:
- Article
Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2051, doi. 10.1007/s00277-021-04407-0
- By:
- Publication type:
- Article
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2005, doi. 10.1007/s00277-020-04392-w
- By:
- Publication type:
- Article
Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2087, doi. 10.1007/s00277-020-04362-2
- By:
- Publication type:
- Article
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1995, doi. 10.1007/s00277-020-04360-4
- By:
- Publication type:
- Article
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2023, doi. 10.1007/s00277-020-04357-z
- By:
- Publication type:
- Article
Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2015, doi. 10.1007/s00277-020-04350-6
- By:
- Publication type:
- Article
Blood and platelet transfusion from a donor with presymptomatic Covid-19.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Plasma hemoglobin in COVID-19: authors' reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 1975, doi. 10.1007/s00277-020-04314-w
- By:
- Publication type:
- Article
Hemolytic erythrocytosis: an amalgamated phenotype from coinherited Chuvash polycythemia and G6PD Kerala-Kalyan with acquired transient stomatocytosis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Elevated plasma hemoglobin in COVID-19–related illnesses: a critical appraisal.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Thrombocytopenia in COVID-19: pathophysiology matters.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report.
- Published in:
- 2021
- By:
- Publication type:
- Letter